This CEO sells low-cost drugs, and he says Big Pharma might not be the true adversary
Briefly

Cost Plus Drugs operates by revealing the purchase price of drugs and adding a $15 fee for shipping, thereby dramatically reducing costs compared to traditional pharmacy pricing. This transparency in pricing is a significant innovation in the pharmaceutical marketplace.
Oshmyansky highlights the existence of a cartel among pharmacy benefit managers who create unnecessary markups in drug pricing. By circumventing this system, Cost Plus Drugs can offer prescriptions at drastically lower prices.
Read at Fast Company
[
|
]